Actively Recruiting

Phase 2
Age: 3Years - 11Years
All Genders
ID06668805

A Phase 2, Randomized, Multicenter Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

Led by BioMarin Pharmaceutical · Updated on 2026-05-11

30

Participants Needed

36

Research Sites

756 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying children with Noonan syndrome who have inadequate growth during or after treatment with human growth hormone (hGH). The study aims to evaluate the effects of three different doses of vosoritide on growth, specifically looking at annualized growth velocity (AGV) after six months of treatment. The long-term safety and effectiveness of vosoritide at the therapeutic dose will be assessed up to when participants reach their final adult height (FAH). This Phase 2, randomized, multicenter trial compares three dosing regimens of vosoritide, which is given as an injection. Participants receive one of three different doses of this experimental drug, provided as a lyophilized powder for reconstitution. The study includes both a short-term evaluation of growth changes over six months and a longer-term assessment of height and safety measures up to 15 years. During the study, children will have regular height measurements and assessments of growth velocity, body proportions, bone density, and bone age. Researchers will also monitor heart conditions, bone-related events, and quality of life using various questionnaires and physical activity scores. Blood and urine tests will track vosoritide levels and biological markers. Safety and growth will be followed every six to twelve months until participants reach their final adult height, which may take up to 15 years.

CONDITIONS

Brief Title

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

Who Can Participate

Age: 3Years - 11Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be 3 years old or older, and under 11 years old for females or under 12 years old for males, at the time of consent.
  • Genetically confirmed diagnosis of Turner syndrome, SHOX deficiency, or Noonan syndrome.
  • Height corresponding to a Z-score of -1.28 or lower (below the 10th percentile) for age and sex.
  • Tanner Stage 1 at the time of consent.
  • Previous or current treatment with human growth hormone for short stature related to their condition.
  • Inadequate growth confirmed by an annualized growth velocity below the average for their age and sex.
Not Eligible

You will not qualify if you...

  • Turner syndrome participants with Y-chromosome material unless they have had gonadectomy and have fully external female genitalia.
  • Diagnosis of other systemic diseases that may cause short stature besides Turner syndrome, SHOX deficiency, or Noonan syndrome.
  • Bone age advanced more than 2 years beyond chronological age.
  • Uncorrected congenital heart disease that increases risk during low blood pressure.
  • Unstable condition likely to need surgical intervention during the study.
  • Evidence of decreased growth velocity less than 1.5 cm/year over at least 6 months and growth plate closure.
  • Previous, planned, or expected limb-lengthening surgery during the study.
  • Planned or expected bone-related surgery during the study, excluding tooth extraction.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - Up to 15 years

Participants receive one of three dosing regimens of vosoritide to evaluate its short-term efficacy and safety for growth improvement.

Regular visits every 6 months for dosing and assessments

Follow-up

Duration - Up to 15 years

Participants are monitored for long-term safety and growth outcomes after treatment ends.

Annual visits for ongoing safety and efficacy assessments

Trial Site Locations

Total: 36 locations

1

Childrens Hospital Los Angeles

Los Angeles, California, United States, 90027

Actively Recruiting

2

Children's Hospital of Orange County Main Campus - Orange

Orange, California, United States, 92868

Actively Recruiting

3

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children)

Wilmington, Delaware, United States, 19803

Actively Recruiting

5

Children's National Medical Center

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

6

Nicklaus Children's Hospital

Miami, Florida, United States, 33155

Not Yet Recruiting

7

Emory University School of Medicine

Atlanta, Georgia, United States, 30322

Actively Recruiting

8

St. Luke's Children's Endocrinology and Diabetes

Boise, Idaho, United States, 83712

Actively Recruiting

9

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60611

Actively Recruiting

10

Riley Hospital for Children at Indiana University Health

Indianapolis, Indiana, United States, 46202

Actively Recruiting

11

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

12

Kentucky Children's Hospital

Lexington, Kentucky, United States, 40506

Actively Recruiting

13

New York Medical College

Boston, Massachusetts, United States, 02115

Actively Recruiting

14

M Health Fairview Pediatric Specialty Clinic - Explorer

Minneapolis, Minnesota, United States, 55454

Actively Recruiting

15

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

16

Children's Hospital at Montefiore

The Bronx, New York, United States, 10467

Actively Recruiting

17

Atrium Health Carolinas Medical Center

Charlotte, North Carolina, United States, 28203

Actively Recruiting

18

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229-3026

Actively Recruiting

19

Childrens Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

20

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232-2578

Actively Recruiting

21

Children's Medical Center Dallas

Dallas, Texas, United States, 75235

Actively Recruiting

22

University of Texas Health Science Center at Houston (UT Health)

Houston, Texas, United States, 77030

Actively Recruiting

23

Royal North Shore Hospital

Saint Leonards, New South Wales, Australia, 2065

Actively Recruiting

24

Childrens Health Queensland Hospital and Health Service

South Brisbane, Queensland, Australia, 4101

Actively Recruiting

25

Murdoch Children's Research Institute

Parkville, Victoria, Australia, 3052

Actively Recruiting

26

M.A.G.I.C. Clinic

Calgary, Alberta, Canada, T2E 7H7

Actively Recruiting

27

Hôpital de la Timone

Marseille, Bouches-du-Rhône, France, 13385

Actively Recruiting

28

Angers University Hospital Center

Angers, Maine-et-Loire, France, 49 933

Actively Recruiting

29

CHU de Toulouse - Hôpital des Enfants

Toulouse, Occitanie, France

Actively Recruiting

30

South Paris University Hospitals - Bicetre Hospital

Le Kremlin-Bicêtre, Paris, France, 94270

Actively Recruiting

31

Hôpital Robert-Debré

Paris, Paris, France, 75019

Actively Recruiting

32

Universitätsklinikum des Saarlandes

Homburg, Saarland, Germany, 66421

Actively Recruiting

33

Azienda Ospedaliero Universitaria - Ospedale Pediatrico Meyer

Florence, Florence, Italy, Firenze

Actively Recruiting

34

IRCCS Istituto Giannina Gaslini

Genova, Genoa, Italy, 16147

Not Yet Recruiting

35

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, Italy, 00 168

Actively Recruiting

36

Central University Hospital of Asturias

Oviedo, Principality of Asturias, Spain, 33011

Not Yet Recruiting

Loading map...

Research Team

T

Trial Specialist

S

Study Manager

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Acceptance and Commitment Therapy for Caregivers of Children...

Neurofibromatosis 1

Actively Recruiting

1 location

Clinical, Genetic, and Epidemiologic Study of Children and A...

Costello Syndrome

Actively Recruiting

2 locations

Constitution of a Biological Collection to Study the Pathoph...

Noonan Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here